# A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

> **NCT07357740** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 400 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** CagriSema
- **DRUG:** Placebo CagriSema

## Key facts

- **NCT ID:** NCT07357740
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-27
- **Primary completion:** 2027-08-25
- **Final completion:** 2027-10-13
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07357740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07357740, "A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07357740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*